
ETHYPHARM to buy Argatroban business from Mitsubishi Tanabe Pharma Group
Frankfurt a. Main — The leading medium-sized international pharmaceutical company Ethypharm S.A.S., Saint-Cloud/France has signed a purchase agreement for the rights to the European Argatroban business of Mitsubishi Tanabe Pharma Corporation, Osaka/Japan and other companies of the Mitsubishi Tanabe Pharma Group. Argatroban monohydrate is a selective antithrombin agent used in the treatment of heparin-induced thrombocytopenia type II (HIT type II). Due to the company structures, the complexity of the rights to the product and the involvement of other operational intermediaries for the manufacture of the Argatroban active ingredient, the transaction was carried out by way of an asset deal.
Ethypharm is a leading mid-sized international pharmaceutical company with strong European roots that manufactures and supplies essential medicines with a focus on hospital care, central nervous system (severe pain and addiction) and internal medicine. The acquisition strengthens Ethypharm’s portfolio of essential medicines.
In addition to Mitsubishi Tanabe Pharma Corporation, the sellers were its subsidiaries Mitsubishi Tanabe Pharma Europe Ltd, London/United Kingdom and Mitsubishi Tanabe Pharma GmbH, Düsseldorf.
Advisor Ethypharm: Schadbach Rechtsanwälte
Kai Schadbach, LL.M. (Photo © Schadbach Rechtsanwälte, lead), Konstantin Warnowizki and Sören Brost (all M&A), Dr. Petra Weipert and Annette Kuhlen-Leis (both employment law) and Dr. Marco Brand (commercial law).
About Schadbach Attorneys at Law
Schadbach Rechtsanwälte is a national and international commercial law firm based in Frankfurt am Main. Our clients are predominantly medium-sized companies and international groups of companies who value our firm’s expertise in corporate law as well as our contractual and transactional experience, e.g. in the M&A and private equity market. In addition to corporate/M&A, other areas of advice include (international) commercial law, directors’ and officers’ liability and procedural law. — www.schadbach.com